NCT00857714View on ClinicalTrials.gov

Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Ductal Carcinoma in Situ
Interventions
DRUG

lapatinib

1500 mg lapatinib for 14-21 days

Trial Locations (1)

46202

Indiana University, Indianapolis

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Indiana University

OTHER